Patients commonly experience neurocognitive deficits such as reduced working memory, slower processing speed and impaired executive function, together with affective symptoms including depression, apathy and anxiety, which heighten the overall neuropsychiatric burden (7)
The Science Behind Better Sleep Research Findings Multiple studies show promising results for GLP-1 therapy and sleep: A 2024 systematic review found that GLP-1 medications significantly reduced sleep apnea severity scores by an average of 6-12 events per hour compared to placebo
Oxidative stress promotes specific protein damage in Saccharomyces cerevisiae
Patient factors still matter too, especially kidney, heart, or liver disease, medication use, allergies, and G6PD status
It is not junk food all day
Applying the current interpretation rules of this method, 60.2% of the samples were scored as genotype 1 and 35% as genotype 6